Get started
AAA

ACTICOR BIOTECH

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

ALACT chart


Full chart

ALACT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪5.50 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.142 EUR
Net income (FY)
‪−18.64 M‬ EUR
Revenue (FY)
0.00 EUR
Shares float
‪6.75 M‬
Beta (1Y)
2.36

Employees


Employees (FY)
28
Change (1Y)
+7 +33.33%
Revenue / Employee (1Y)
0.00 EUR
Net income / Employee (1Y)
‪−734.78 K‬ EUR

About ACTICOR BIOTECH


Sector
Health Technology
Industry
Biotechnology
CEO
Gilles Avenard
Website
acticor-biotech.com
Headquarters
Paris
Founded
2013
ISIN
FR0014005OJ5
FIGI
BBG0131M76J1
Acticor Biotech SAS engages in the research and development of an antithrombotic agent for the treatment of the acute thrombotic diseases. It specializes on ischemic stroke. The company was founded on November 26, 2013 and is headquartered in Paris, France.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ALACT news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ALACT is 0.330 EUR — it has decreased by −5.44% in the past 24 hours. Watch ACTICOR BIOTECH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange ACTICOR BIOTECH stocks are traded under the ticker ALACT.
ALACT stock has fallen by −18.11% compared to the previous week, the month change is a −51.33% fall, over the last year ACTICOR BIOTECH has showed a −91.34% decrease.
ALACT reached its all-time high on Feb 10, 2023 with the price of 11.000 EUR, and its all-time low was 0.220 EUR and was reached on Sep 30, 2024. View more price dynamics on ALACT chart.
See other stocks reaching their highest and lowest prices.
ALACT stock is 9.09% volatile and has beta coefficient of 2.36. Track ACTICOR BIOTECH stock price on the chart and check out the list of the most volatile stocks — is ACTICOR BIOTECH there?
Today ACTICOR BIOTECH has the market capitalization of ‪5.50 M‬, it has decreased by −24.44% over the last week.
Yes, you can track ACTICOR BIOTECH financials in yearly and quarterly reports right on TradingView.
ACTICOR BIOTECH is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ALACT net income for the last half-year is ‪−7.30 M‬ EUR, while the previous report showed ‪−8.56 M‬ EUR of net income which accounts for 14.65% change. Track more ACTICOR BIOTECH financial stats to get the full picture.
No, ALACT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 14, 2024, the company has 28.00 employees. See our rating of the largest employees — is ACTICOR BIOTECH on this list?
Like other stocks, ALACT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACTICOR BIOTECH stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ACTICOR BIOTECH technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ACTICOR BIOTECH stock shows the strong sell signal. See more of ACTICOR BIOTECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.